The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib Anand A. PatelOlatoyosi Odenike Myeloproliferative Neoplasms (B Stein, Section Editor) 11 August 2020 Pages: 409 - 418
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges Jessica S. LittleRizwan Romee Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 11 November 2020 Pages: 419 - 423
New Approaches to Treating Challenging Subtypes of ALL in AYA Patients Kevin PrescottMichael JacobsJoseph Wynne Acute Lymphocytic Leukemias (K Ballen and M Keng, Section Editors) 12 September 2020 Pages: 424 - 435